clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
U.K.’s Huge Newborn Screening Study Takes Off
News & Features
Clinical Trial Shows Synthetic THC Reduces Agitation in Alzheimer’s Disease
News & Features
AI Detects Breast Cancer Years Before Its Diagnosis
News & Features
Carnegie Mellon Nets $80M+ For Cell-Based Bioelectronics to Monitor and Treat…
News & Features
Anti-Inflammatory Marker Holds Promise for Cardiovascular Vaccine
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Agilent Revs up Precision Medicine Push with Planned Resolution Bioscience Acquisition
Agilent
Molecular Dx
Agilent Revs up Precision Medicine Push with Planned Resolution Bioscience Acquisition
March 3, 2021
0
Molecular Dx
Agilent and Visiopharm Plan to Merge Resources to Market Complimentary Cancer Diagnosis Technology
March 4, 2020
0
News & Features
Top 10 Sequencing Companies
April 8, 2019
0
Molecular Dx
Cancer Dx Developer Burning Rock Completes $125.5M Series C Round
February 14, 2019
0
Molecular Dx
Agilent CDx for Keytruda Gets FDA Approval for Cervical Cancer
June 13, 2018
0
News & Features
Integrated Metabolic Analysis and Imaging Platform
May 10, 2018
0
Molecular Dx
Top 10 Sequencing Companies
April 9, 2018
0
Molecular Dx
Agilent Buys Lasergen for $105M, Two Years after Taking 48% Stake
April 5, 2018
0
News & Features
ASHG Day 2 News Digest: Fabric Genomics, Edico Genome, Agilent, Invitae, and More
October 19, 2017
0
News & Features
Agilent Wins Expanded Use in Europe for Opdivo Diagnostic in Urothelial Cancer
June 16, 2017
0
1
2
Page 1 of 2
Related Content
Anti-Inflammatory Marker Holds Promise for Cardiovascular Vaccine
Anti-Cancer Antibodies May Aid Early Melanoma Detection
Owkin and AstraZeneca Partner on AI-Powered gBRCA Screening for Breast Cancer
Proscia Builds Platform to Accelerate Custom AI-Based Pathology Solutions
Inside Precision Medicine
![Agilent Technologies’ Dako PD-L1 IHC 22C3 pharmDx assay has become the first FDA-approved companion diagnostic to identify patients with cervical cancer for treatment with Merck & Co.'s cancer immunotherapy Keytruda (pembrolizumab). [Agilent Technologies]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1724-768x218.jpeg "Agilent CDx for Keytruda Gets FDA Approval for Cervical Cancer")
![Agilent Technologies has won expanded use for its Dako PD-L1 IHC 28-8 pharmDx test in Europe for patients with urothelial cancer who are mosty likely to benefit from treatment with Opdivo.[Agilent Technologies]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1133.jpeg "Agilent Wins Expanded Use in Europe for Opdivo Diagnostic in Urothelial Cancer")
